Soranib Tablet

Soranib Tablet

Product Details:

  • Salt Composition Sorafenib 200 mg
  • Dosage Form Tablet
  • Indication Used for the treatment of advanced renal cell carcinoma and hepatocellular carcinoma
  • Feature Oral multi-kinase inhibitor for targeted cancer therapy
  • Ingredients Active ingredient: Sorafenib Tosylate; Excipients: as per formulation
  • Application Anticancer medication
  • Physical Color/Texture Light yellow, capsule-shaped tablets
  • Click to View more
X

Soranib Tablet Product Specifications

  • Anticancer medication
  • Used for the treatment of advanced renal cell carcinoma and hepatocellular carcinoma
  • Light yellow, capsule-shaped tablets
  • Oral multi-kinase inhibitor for targeted cancer therapy
  • Tablet
  • Active ingredient: Sorafenib Tosylate; Excipients: as per formulation
  • Sorafenib 200 mg
  • 24 months from manufacture
  • Store below 25C, protect from moisture
  • Prescription only medicine
  • Known hypersensitivity to Sorafenib or excipients
  • 200 mg
  • As directed by an oncologist
  • 30 tablets per bottle
  • FDA/EMA approved indications
  • Oral
  • HDPE bottle
  • Film-coated tablet
  • Antineoplastic agents

Soranib Tablet Trade Information

  • 30 Per Day
  • 1 Week
  • Yes
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

Banking upon in-depth domain knowledge and years of vast experience we have been able to emerge as a trusted organization engaged in offering Soranib Tablet. This tablet is used in the treatment of liver cancer, advanced stage kidney cancer and thyroid cancer. Soranib Tablet helps in cutting down the blood supply to cancer cells and stops their growth. We offer this tablet at reasonable prices to clients.

Features:

  • Slows down the growth of cancer cells
  • Effective in chemotherapy of liver cancer 
  • Accurate composition 

Specifications:

  • Content : Sorafenib
  • Form : Tablets
  • Strength : 200 mg
  • Packing : New Pack of 30 Tablets
  • Available as : 200 mg Tablets
  • Manufactured By : CIPLA


Targeted Therapy for Cancer

Soranib Tablet utilizes Sorafenib Tosylate, a multi-kinase inhibitor, facilitating targeted therapy against advanced renal cell and hepatocellular cancers. This approach helps manage tumor growth and progression with precision, aiming to improve patient survival and quality of life.


Quality and Regulatory Assurance

Manufactured for export, trade, and distribution in India, Soranib Tablet comes in robust HDPE bottles and complies with FDA and EMA regulations. Each batch delivers consistent potency, with a 24-month shelf life when stored below 25C and protected from moisture.

FAQs of Soranib Tablet:


Q: How should Soranib Tablet be taken for optimal effectiveness?

A: Soranib Tablet is administered orally as per dosage instructions provided by your oncologist. Follow the prescribed schedule closely and avoid altering the dose without consulting your healthcare professional.

Q: What are the approved medical uses of Soranib Tablet?

A: Soranib Tablet is indicated for the treatment of advanced renal cell carcinoma and hepatocellular carcinoma, as approved by the FDA and EMA for these specific cancer types.

Q: When is Soranib Tablet contraindicated?

A: Soranib Tablet should not be used in individuals with known hypersensitivity to Sorafenib or any of the tablets excipients as listed in the product formulation.

Q: Where should Soranib Tablets be stored for maximum shelf life?

A: Store Soranib Tablets in their original HDPE bottle below 25C and protect them from moisture. Proper storage ensures efficacy and extends shelf life up to 24 months from manufacture.

Q: What is the process for acquiring Soranib Tablet?

A: Soranib Tablet is a prescription-only medication. Patients must consult their oncologist, who will determine the appropriateness and provide a prescription for treatment initiation.

Q: What are the therapeutic benefits of using Soranib Tablet?

A: Soranib Tablet offers a targeted approach to treating certain cancers by inhibiting multiple kinases involved in tumor growth and angiogenesis, potentially improving treatment outcomes and controlling disease progression.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Tablets' category



We Mainly Deal in International Market.
Back to top